- MSK researchers collaborated with their counterparts from Columbia University, MD Anderson Cancer Center and the University of Michigan, among others, to determine which complementary treatments are tops in effectiveness and safety for patients newly diagnosed with breast cancer. The evidence showed that meditation, yoga and relaxation with imagery were most effective.
- An article published on 10-27-14 describes the results of a study which utilized the precise cancer monitoring technology of Trovagene, Inc., producer of cell-free molecular diagnostics. The study was carried out by Dr. Eli L. Diamond, an MSK neuro-oncologist. The technology makes possible a non-invasive determination of oncogene mutation status and tracks response to BRAF inhibitor therapy in patients with histiocytic disease, a malignant condition associated with BRAF mutations.
- A project carried out to enhance the comfort levels of patients at MSK’s Kimmel Center won an award from the Building Commissioning Association. When completed, the work done provided the added benefit of reducing the building’s energy consumption.